
ALT Bar graph showing the percentage of patients on the Modified Rankin Scale, comparing "EVT plus Medical Management" (N=144) and "Medical Management Alone" (N=156). Scores range from 0 to 6. The distribution is labeled with percentages and number of patients for each category.

ALT A forest plot comparing EVT plus Medical Management to Medical Management Alone for various subgroups, showing adjusted odds ratios and confidence intervals. Subgroups include age, sex, time from onset to randomization, site of occlusion, cause of stroke, baseline NIHSS score, intravenous thrombolysis, and perfusion-mismatch volume.

ALT A graph from an Original Article published in the New England Journal of Medicine article titled "Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity." The graph shows effect of retatrutide on body weight. The trial name, TRIUMPH-1, is in parentheses after the title. The NEJM identity sits at the bottom.










































